Global Viral Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Viral Vaccines market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Viral Vaccines industry chain, the market status of Hospital (Attenuated Vaccine, Inactivated Vaccine), Pharmaceutical Factory (Attenuated Vaccine, Inactivated Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Viral Vaccines.
Regionally, the report analyzes the Viral Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Viral Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Viral Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Viral Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Attenuated Vaccine, Inactivated Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Viral Vaccines market.
Regional Analysis: The report involves examining the Viral Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Viral Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Viral Vaccines:
Company Analysis: Report covers individual Viral Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Viral Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Pharmaceutical Factory).
Technology Analysis: Report covers specific technologies relevant to Viral Vaccines. It assesses the current state, advancements, and potential future developments in Viral Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Viral Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Viral Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Viral Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Viral Vaccines, with price, sales, revenue and global market share of Viral Vaccines from 2019 to 2024.
Chapter 3, the Viral Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Viral Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Viral Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Viral Vaccines.
Chapter 14 and 15, to describe Viral Vaccines sales channel, distributors, customers, research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Viral Vaccines industry chain, the market status of Hospital (Attenuated Vaccine, Inactivated Vaccine), Pharmaceutical Factory (Attenuated Vaccine, Inactivated Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Viral Vaccines.
Regionally, the report analyzes the Viral Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Viral Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Viral Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Viral Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Attenuated Vaccine, Inactivated Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Viral Vaccines market.
Regional Analysis: The report involves examining the Viral Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Viral Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Viral Vaccines:
Company Analysis: Report covers individual Viral Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Viral Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Pharmaceutical Factory).
Technology Analysis: Report covers specific technologies relevant to Viral Vaccines. It assesses the current state, advancements, and potential future developments in Viral Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Viral Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Viral Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Attenuated Vaccine
- Inactivated Vaccine
- Hospital
- Pharmaceutical Factory
- Research Institute
- Others
- GSK
- Merck
- Novartis
- Pfizer
- Sanofi
- Bayer
- Zoetis
- AstraZeneca
- Johnson
- CSL
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Viral Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Viral Vaccines, with price, sales, revenue and global market share of Viral Vaccines from 2019 to 2024.
Chapter 3, the Viral Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Viral Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Viral Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Viral Vaccines.
Chapter 14 and 15, to describe Viral Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Viral Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Viral Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Attenuated Vaccine
1.3.3 Inactivated Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Viral Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Pharmaceutical Factory
1.4.4 Research Institute
1.4.5 Others
1.5 Global Viral Vaccines Market Size & Forecast
1.5.1 Global Viral Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Viral Vaccines Sales Quantity (2019-2030)
1.5.3 Global Viral Vaccines Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Viral Vaccines Product and Services
2.1.4 GSK Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Viral Vaccines Product and Services
2.2.4 Merck Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Viral Vaccines Product and Services
2.3.4 Novartis Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Viral Vaccines Product and Services
2.4.4 Pfizer Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments/Updates
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Viral Vaccines Product and Services
2.5.4 Sanofi Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sanofi Recent Developments/Updates
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business
2.6.3 Bayer Viral Vaccines Product and Services
2.6.4 Bayer Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bayer Recent Developments/Updates
2.7 Zoetis
2.7.1 Zoetis Details
2.7.2 Zoetis Major Business
2.7.3 Zoetis Viral Vaccines Product and Services
2.7.4 Zoetis Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Zoetis Recent Developments/Updates
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Viral Vaccines Product and Services
2.8.4 AstraZeneca Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 AstraZeneca Recent Developments/Updates
2.9 Johnson
2.9.1 Johnson Details
2.9.2 Johnson Major Business
2.9.3 Johnson Viral Vaccines Product and Services
2.9.4 Johnson Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Johnson Recent Developments/Updates
2.10 CSL
2.10.1 CSL Details
2.10.2 CSL Major Business
2.10.3 CSL Viral Vaccines Product and Services
2.10.4 CSL Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 CSL Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: VIRAL VACCINES BY MANUFACTURER
3.1 Global Viral Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Viral Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global Viral Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Viral Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Viral Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 Viral Vaccines Manufacturer Market Share in 2023
3.5 Viral Vaccines Market: Overall Company Footprint Analysis
3.5.1 Viral Vaccines Market: Region Footprint
3.5.2 Viral Vaccines Market: Company Product Type Footprint
3.5.3 Viral Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Viral Vaccines Market Size by Region
4.1.1 Global Viral Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global Viral Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global Viral Vaccines Average Price by Region (2019-2030)
4.2 North America Viral Vaccines Consumption Value (2019-2030)
4.3 Europe Viral Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific Viral Vaccines Consumption Value (2019-2030)
4.5 South America Viral Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa Viral Vaccines Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Viral Vaccines Sales Quantity by Type (2019-2030)
5.2 Global Viral Vaccines Consumption Value by Type (2019-2030)
5.3 Global Viral Vaccines Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Viral Vaccines Sales Quantity by Application (2019-2030)
6.2 Global Viral Vaccines Consumption Value by Application (2019-2030)
6.3 Global Viral Vaccines Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Viral Vaccines Sales Quantity by Type (2019-2030)
7.2 North America Viral Vaccines Sales Quantity by Application (2019-2030)
7.3 North America Viral Vaccines Market Size by Country
7.3.1 North America Viral Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America Viral Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Viral Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe Viral Vaccines Sales Quantity by Application (2019-2030)
8.3 Europe Viral Vaccines Market Size by Country
8.3.1 Europe Viral Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe Viral Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Viral Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Viral Vaccines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Viral Vaccines Market Size by Region
9.3.1 Asia-Pacific Viral Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Viral Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Viral Vaccines Sales Quantity by Type (2019-2030)
10.2 South America Viral Vaccines Sales Quantity by Application (2019-2030)
10.3 South America Viral Vaccines Market Size by Country
10.3.1 South America Viral Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America Viral Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Viral Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Viral Vaccines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Viral Vaccines Market Size by Country
11.3.1 Middle East & Africa Viral Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Viral Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Viral Vaccines Market Drivers
12.2 Viral Vaccines Market Restraints
12.3 Viral Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Viral Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Viral Vaccines
13.3 Viral Vaccines Production Process
13.4 Viral Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Viral Vaccines Typical Distributors
14.3 Viral Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Viral Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Viral Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Attenuated Vaccine
1.3.3 Inactivated Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Viral Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Pharmaceutical Factory
1.4.4 Research Institute
1.4.5 Others
1.5 Global Viral Vaccines Market Size & Forecast
1.5.1 Global Viral Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Viral Vaccines Sales Quantity (2019-2030)
1.5.3 Global Viral Vaccines Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Viral Vaccines Product and Services
2.1.4 GSK Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Viral Vaccines Product and Services
2.2.4 Merck Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Viral Vaccines Product and Services
2.3.4 Novartis Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Viral Vaccines Product and Services
2.4.4 Pfizer Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments/Updates
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Viral Vaccines Product and Services
2.5.4 Sanofi Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sanofi Recent Developments/Updates
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business
2.6.3 Bayer Viral Vaccines Product and Services
2.6.4 Bayer Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bayer Recent Developments/Updates
2.7 Zoetis
2.7.1 Zoetis Details
2.7.2 Zoetis Major Business
2.7.3 Zoetis Viral Vaccines Product and Services
2.7.4 Zoetis Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Zoetis Recent Developments/Updates
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Viral Vaccines Product and Services
2.8.4 AstraZeneca Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 AstraZeneca Recent Developments/Updates
2.9 Johnson
2.9.1 Johnson Details
2.9.2 Johnson Major Business
2.9.3 Johnson Viral Vaccines Product and Services
2.9.4 Johnson Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Johnson Recent Developments/Updates
2.10 CSL
2.10.1 CSL Details
2.10.2 CSL Major Business
2.10.3 CSL Viral Vaccines Product and Services
2.10.4 CSL Viral Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 CSL Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: VIRAL VACCINES BY MANUFACTURER
3.1 Global Viral Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Viral Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global Viral Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Viral Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Viral Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 Viral Vaccines Manufacturer Market Share in 2023
3.5 Viral Vaccines Market: Overall Company Footprint Analysis
3.5.1 Viral Vaccines Market: Region Footprint
3.5.2 Viral Vaccines Market: Company Product Type Footprint
3.5.3 Viral Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Viral Vaccines Market Size by Region
4.1.1 Global Viral Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global Viral Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global Viral Vaccines Average Price by Region (2019-2030)
4.2 North America Viral Vaccines Consumption Value (2019-2030)
4.3 Europe Viral Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific Viral Vaccines Consumption Value (2019-2030)
4.5 South America Viral Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa Viral Vaccines Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Viral Vaccines Sales Quantity by Type (2019-2030)
5.2 Global Viral Vaccines Consumption Value by Type (2019-2030)
5.3 Global Viral Vaccines Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Viral Vaccines Sales Quantity by Application (2019-2030)
6.2 Global Viral Vaccines Consumption Value by Application (2019-2030)
6.3 Global Viral Vaccines Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Viral Vaccines Sales Quantity by Type (2019-2030)
7.2 North America Viral Vaccines Sales Quantity by Application (2019-2030)
7.3 North America Viral Vaccines Market Size by Country
7.3.1 North America Viral Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America Viral Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Viral Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe Viral Vaccines Sales Quantity by Application (2019-2030)
8.3 Europe Viral Vaccines Market Size by Country
8.3.1 Europe Viral Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe Viral Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Viral Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Viral Vaccines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Viral Vaccines Market Size by Region
9.3.1 Asia-Pacific Viral Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Viral Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Viral Vaccines Sales Quantity by Type (2019-2030)
10.2 South America Viral Vaccines Sales Quantity by Application (2019-2030)
10.3 South America Viral Vaccines Market Size by Country
10.3.1 South America Viral Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America Viral Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Viral Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Viral Vaccines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Viral Vaccines Market Size by Country
11.3.1 Middle East & Africa Viral Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Viral Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Viral Vaccines Market Drivers
12.2 Viral Vaccines Market Restraints
12.3 Viral Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Viral Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Viral Vaccines
13.3 Viral Vaccines Production Process
13.4 Viral Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Viral Vaccines Typical Distributors
14.3 Viral Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Viral Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Viral Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Viral Vaccines Product and Services
Table 6. GSK Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GSK Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck Viral Vaccines Product and Services
Table 11. Merck Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Merck Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis Viral Vaccines Product and Services
Table 16. Novartis Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Novartis Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Viral Vaccines Product and Services
Table 21. Pfizer Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Pfizer Recent Developments/Updates
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Viral Vaccines Product and Services
Table 26. Sanofi Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Sanofi Recent Developments/Updates
Table 28. Bayer Basic Information, Manufacturing Base and Competitors
Table 29. Bayer Major Business
Table 30. Bayer Viral Vaccines Product and Services
Table 31. Bayer Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Bayer Recent Developments/Updates
Table 33. Zoetis Basic Information, Manufacturing Base and Competitors
Table 34. Zoetis Major Business
Table 35. Zoetis Viral Vaccines Product and Services
Table 36. Zoetis Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Zoetis Recent Developments/Updates
Table 38. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 39. AstraZeneca Major Business
Table 40. AstraZeneca Viral Vaccines Product and Services
Table 41. AstraZeneca Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. AstraZeneca Recent Developments/Updates
Table 43. Johnson Basic Information, Manufacturing Base and Competitors
Table 44. Johnson Major Business
Table 45. Johnson Viral Vaccines Product and Services
Table 46. Johnson Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Johnson Recent Developments/Updates
Table 48. CSL Basic Information, Manufacturing Base and Competitors
Table 49. CSL Major Business
Table 50. CSL Viral Vaccines Product and Services
Table 51. CSL Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. CSL Recent Developments/Updates
Table 53. Global Viral Vaccines Sales Quantity by Manufacturer (2019-2024) & (K MT)
Table 54. Global Viral Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Viral Vaccines Average Price by Manufacturer (2019-2024) & (USD/MT)
Table 56. Market Position of Manufacturers in Viral Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Viral Vaccines Production Site of Key Manufacturer
Table 58. Viral Vaccines Market: Company Product Type Footprint
Table 59. Viral Vaccines Market: Company Product Application Footprint
Table 60. Viral Vaccines New Market Entrants and Barriers to Market Entry
Table 61. Viral Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Viral Vaccines Sales Quantity by Region (2019-2024) & (K MT)
Table 63. Global Viral Vaccines Sales Quantity by Region (2025-2030) & (K MT)
Table 64. Global Viral Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Viral Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Viral Vaccines Average Price by Region (2019-2024) & (USD/MT)
Table 67. Global Viral Vaccines Average Price by Region (2025-2030) & (USD/MT)
Table 68. Global Viral Vaccines Sales Quantity by Type (2019-2024) & (K MT)
Table 69. Global Viral Vaccines Sales Quantity by Type (2025-2030) & (K MT)
Table 70. Global Viral Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Viral Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Viral Vaccines Average Price by Type (2019-2024) & (USD/MT)
Table 73. Global Viral Vaccines Average Price by Type (2025-2030) & (USD/MT)
Table 74. Global Viral Vaccines Sales Quantity by Application (2019-2024) & (K MT)
Table 75. Global Viral Vaccines Sales Quantity by Application (2025-2030) & (K MT)
Table 76. Global Viral Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Viral Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Viral Vaccines Average Price by Application (2019-2024) & (USD/MT)
Table 79. Global Viral Vaccines Average Price by Application (2025-2030) & (USD/MT)
Table 80. North America Viral Vaccines Sales Quantity by Type (2019-2024) & (K MT)
Table 81. North America Viral Vaccines Sales Quantity by Type (2025-2030) & (K MT)
Table 82. North America Viral Vaccines Sales Quantity by Application (2019-2024) & (K MT)
Table 83. North America Viral Vaccines Sales Quantity by Application (2025-2030) & (K MT)
Table 84. North America Viral Vaccines Sales Quantity by Country (2019-2024) & (K MT)
Table 85. North America Viral Vaccines Sales Quantity by Country (2025-2030) & (K MT)
Table 86. North America Viral Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Viral Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Viral Vaccines Sales Quantity by Type (2019-2024) & (K MT)
Table 89. Europe Viral Vaccines Sales Quantity by Type (2025-2030) & (K MT)
Table 90. Europe Viral Vaccines Sales Quantity by Application (2019-2024) & (K MT)
Table 91. Europe Viral Vaccines Sales Quantity by Application (2025-2030) & (K MT)
Table 92. Europe Viral Vaccines Sales Quantity by Country (2019-2024) & (K MT)
Table 93. Europe Viral Vaccines Sales Quantity by Country (2025-2030) & (K MT)
Table 94. Europe Viral Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Viral Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Viral Vaccines Sales Quantity by Type (2019-2024) & (K MT)
Table 97. Asia-Pacific Viral Vaccines Sales Quantity by Type (2025-2030) & (K MT)
Table 98. Asia-Pacific Viral Vaccines Sales Quantity by Application (2019-2024) & (K MT)
Table 99. Asia-Pacific Viral Vaccines Sales Quantity by Application (2025-2030) & (K MT)
Table 100. Asia-Pacific Viral Vaccines Sales Quantity by Region (2019-2024) & (K MT)
Table 101. Asia-Pacific Viral Vaccines Sales Quantity by Region (2025-2030) & (K MT)
Table 102. Asia-Pacific Viral Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Viral Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Viral Vaccines Sales Quantity by Type (2019-2024) & (K MT)
Table 105. South America Viral Vaccines Sales Quantity by Type (2025-2030) & (K MT)
Table 106. South America Viral Vaccines Sales Quantity by Application (2019-2024) & (K MT)
Table 107. South America Viral Vaccines Sales Quantity by Application (2025-2030) & (K MT)
Table 108. South America Viral Vaccines Sales Quantity by Country (2019-2024) & (K MT)
Table 109. South America Viral Vaccines Sales Quantity by Country (2025-2030) & (K MT)
Table 110. South America Viral Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Viral Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Viral Vaccines Sales Quantity by Type (2019-2024) & (K MT)
Table 113. Middle East & Africa Viral Vaccines Sales Quantity by Type (2025-2030) & (K MT)
Table 114. Middle East & Africa Viral Vaccines Sales Quantity by Application (2019-2024) & (K MT)
Table 115. Middle East & Africa Viral Vaccines Sales Quantity by Application (2025-2030) & (K MT)
Table 116. Middle East & Africa Viral Vaccines Sales Quantity by Region (2019-2024) & (K MT)
Table 117. Middle East & Africa Viral Vaccines Sales Quantity by Region (2025-2030) & (K MT)
Table 118. Middle East & Africa Viral Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Viral Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Viral Vaccines Raw Material
Table 121. Key Manufacturers of Viral Vaccines Raw Materials
Table 122. Viral Vaccines Typical Distributors
Table 123. Viral Vaccines Typical Customers
Table 1. Global Viral Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Viral Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Viral Vaccines Product and Services
Table 6. GSK Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GSK Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck Viral Vaccines Product and Services
Table 11. Merck Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Merck Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis Viral Vaccines Product and Services
Table 16. Novartis Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Novartis Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Viral Vaccines Product and Services
Table 21. Pfizer Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Pfizer Recent Developments/Updates
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Viral Vaccines Product and Services
Table 26. Sanofi Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Sanofi Recent Developments/Updates
Table 28. Bayer Basic Information, Manufacturing Base and Competitors
Table 29. Bayer Major Business
Table 30. Bayer Viral Vaccines Product and Services
Table 31. Bayer Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Bayer Recent Developments/Updates
Table 33. Zoetis Basic Information, Manufacturing Base and Competitors
Table 34. Zoetis Major Business
Table 35. Zoetis Viral Vaccines Product and Services
Table 36. Zoetis Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Zoetis Recent Developments/Updates
Table 38. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 39. AstraZeneca Major Business
Table 40. AstraZeneca Viral Vaccines Product and Services
Table 41. AstraZeneca Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. AstraZeneca Recent Developments/Updates
Table 43. Johnson Basic Information, Manufacturing Base and Competitors
Table 44. Johnson Major Business
Table 45. Johnson Viral Vaccines Product and Services
Table 46. Johnson Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Johnson Recent Developments/Updates
Table 48. CSL Basic Information, Manufacturing Base and Competitors
Table 49. CSL Major Business
Table 50. CSL Viral Vaccines Product and Services
Table 51. CSL Viral Vaccines Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. CSL Recent Developments/Updates
Table 53. Global Viral Vaccines Sales Quantity by Manufacturer (2019-2024) & (K MT)
Table 54. Global Viral Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Viral Vaccines Average Price by Manufacturer (2019-2024) & (USD/MT)
Table 56. Market Position of Manufacturers in Viral Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Viral Vaccines Production Site of Key Manufacturer
Table 58. Viral Vaccines Market: Company Product Type Footprint
Table 59. Viral Vaccines Market: Company Product Application Footprint
Table 60. Viral Vaccines New Market Entrants and Barriers to Market Entry
Table 61. Viral Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Viral Vaccines Sales Quantity by Region (2019-2024) & (K MT)
Table 63. Global Viral Vaccines Sales Quantity by Region (2025-2030) & (K MT)
Table 64. Global Viral Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Viral Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Viral Vaccines Average Price by Region (2019-2024) & (USD/MT)
Table 67. Global Viral Vaccines Average Price by Region (2025-2030) & (USD/MT)
Table 68. Global Viral Vaccines Sales Quantity by Type (2019-2024) & (K MT)
Table 69. Global Viral Vaccines Sales Quantity by Type (2025-2030) & (K MT)
Table 70. Global Viral Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Viral Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Viral Vaccines Average Price by Type (2019-2024) & (USD/MT)
Table 73. Global Viral Vaccines Average Price by Type (2025-2030) & (USD/MT)
Table 74. Global Viral Vaccines Sales Quantity by Application (2019-2024) & (K MT)
Table 75. Global Viral Vaccines Sales Quantity by Application (2025-2030) & (K MT)
Table 76. Global Viral Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Viral Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Viral Vaccines Average Price by Application (2019-2024) & (USD/MT)
Table 79. Global Viral Vaccines Average Price by Application (2025-2030) & (USD/MT)
Table 80. North America Viral Vaccines Sales Quantity by Type (2019-2024) & (K MT)
Table 81. North America Viral Vaccines Sales Quantity by Type (2025-2030) & (K MT)
Table 82. North America Viral Vaccines Sales Quantity by Application (2019-2024) & (K MT)
Table 83. North America Viral Vaccines Sales Quantity by Application (2025-2030) & (K MT)
Table 84. North America Viral Vaccines Sales Quantity by Country (2019-2024) & (K MT)
Table 85. North America Viral Vaccines Sales Quantity by Country (2025-2030) & (K MT)
Table 86. North America Viral Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Viral Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Viral Vaccines Sales Quantity by Type (2019-2024) & (K MT)
Table 89. Europe Viral Vaccines Sales Quantity by Type (2025-2030) & (K MT)
Table 90. Europe Viral Vaccines Sales Quantity by Application (2019-2024) & (K MT)
Table 91. Europe Viral Vaccines Sales Quantity by Application (2025-2030) & (K MT)
Table 92. Europe Viral Vaccines Sales Quantity by Country (2019-2024) & (K MT)
Table 93. Europe Viral Vaccines Sales Quantity by Country (2025-2030) & (K MT)
Table 94. Europe Viral Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Viral Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Viral Vaccines Sales Quantity by Type (2019-2024) & (K MT)
Table 97. Asia-Pacific Viral Vaccines Sales Quantity by Type (2025-2030) & (K MT)
Table 98. Asia-Pacific Viral Vaccines Sales Quantity by Application (2019-2024) & (K MT)
Table 99. Asia-Pacific Viral Vaccines Sales Quantity by Application (2025-2030) & (K MT)
Table 100. Asia-Pacific Viral Vaccines Sales Quantity by Region (2019-2024) & (K MT)
Table 101. Asia-Pacific Viral Vaccines Sales Quantity by Region (2025-2030) & (K MT)
Table 102. Asia-Pacific Viral Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Viral Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Viral Vaccines Sales Quantity by Type (2019-2024) & (K MT)
Table 105. South America Viral Vaccines Sales Quantity by Type (2025-2030) & (K MT)
Table 106. South America Viral Vaccines Sales Quantity by Application (2019-2024) & (K MT)
Table 107. South America Viral Vaccines Sales Quantity by Application (2025-2030) & (K MT)
Table 108. South America Viral Vaccines Sales Quantity by Country (2019-2024) & (K MT)
Table 109. South America Viral Vaccines Sales Quantity by Country (2025-2030) & (K MT)
Table 110. South America Viral Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Viral Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Viral Vaccines Sales Quantity by Type (2019-2024) & (K MT)
Table 113. Middle East & Africa Viral Vaccines Sales Quantity by Type (2025-2030) & (K MT)
Table 114. Middle East & Africa Viral Vaccines Sales Quantity by Application (2019-2024) & (K MT)
Table 115. Middle East & Africa Viral Vaccines Sales Quantity by Application (2025-2030) & (K MT)
Table 116. Middle East & Africa Viral Vaccines Sales Quantity by Region (2019-2024) & (K MT)
Table 117. Middle East & Africa Viral Vaccines Sales Quantity by Region (2025-2030) & (K MT)
Table 118. Middle East & Africa Viral Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Viral Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Viral Vaccines Raw Material
Table 121. Key Manufacturers of Viral Vaccines Raw Materials
Table 122. Viral Vaccines Typical Distributors
Table 123. Viral Vaccines Typical Customers
LIST OF FIGURES
Figure 1. Viral Vaccines Picture
Figure 2. Global Viral Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Viral Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Attenuated Vaccine Examples
Figure 5. Inactivated Vaccine Examples
Figure 6. Global Viral Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Viral Vaccines Consumption Value Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. Pharmaceutical Factory Examples
Figure 10. Research Institute Examples
Figure 11. Others Examples
Figure 12. Global Viral Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Viral Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Viral Vaccines Sales Quantity (2019-2030) & (K MT)
Figure 15. Global Viral Vaccines Average Price (2019-2030) & (USD/MT)
Figure 16. Global Viral Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Viral Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Viral Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Viral Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Viral Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Viral Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Viral Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Viral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Viral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Viral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Viral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Viral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Viral Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Viral Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Viral Vaccines Average Price by Type (2019-2030) & (USD/MT)
Figure 31. Global Viral Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Viral Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Viral Vaccines Average Price by Application (2019-2030) & (USD/MT)
Figure 34. North America Viral Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Viral Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Viral Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Viral Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Viral Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Viral Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Viral Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Viral Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Viral Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Viral Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Viral Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Viral Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 54. China Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Viral Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Viral Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Viral Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Viral Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Viral Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Viral Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Viral Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Viral Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Viral Vaccines Market Drivers
Figure 75. Viral Vaccines Market Restraints
Figure 76. Viral Vaccines Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Viral Vaccines in 2023
Figure 79. Manufacturing Process Analysis of Viral Vaccines
Figure 80. Viral Vaccines Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Viral Vaccines Picture
Figure 2. Global Viral Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Viral Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Attenuated Vaccine Examples
Figure 5. Inactivated Vaccine Examples
Figure 6. Global Viral Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Viral Vaccines Consumption Value Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. Pharmaceutical Factory Examples
Figure 10. Research Institute Examples
Figure 11. Others Examples
Figure 12. Global Viral Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Viral Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Viral Vaccines Sales Quantity (2019-2030) & (K MT)
Figure 15. Global Viral Vaccines Average Price (2019-2030) & (USD/MT)
Figure 16. Global Viral Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Viral Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Viral Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Viral Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Viral Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Viral Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Viral Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Viral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Viral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Viral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Viral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Viral Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Viral Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Viral Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Viral Vaccines Average Price by Type (2019-2030) & (USD/MT)
Figure 31. Global Viral Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Viral Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Viral Vaccines Average Price by Application (2019-2030) & (USD/MT)
Figure 34. North America Viral Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Viral Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Viral Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Viral Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Viral Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Viral Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Viral Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Viral Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Viral Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Viral Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Viral Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Viral Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 54. China Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Viral Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Viral Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Viral Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Viral Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Viral Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Viral Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Viral Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Viral Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Viral Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Viral Vaccines Market Drivers
Figure 75. Viral Vaccines Market Restraints
Figure 76. Viral Vaccines Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Viral Vaccines in 2023
Figure 79. Manufacturing Process Analysis of Viral Vaccines
Figure 80. Viral Vaccines Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
